A study led by Karolinska Institutet suggests that statins may slow the progression of Alzheimer’s disease in some patients. The study found that people with Alzheimer’s dementia who were treated with statins experienced slower cognitive decline compared to those who were not treated with statins. However, the study was observational and could not establish a causal relationship between statin use and cognitive decline in Alzheimer’s disease. The study included data from over 15,500 patients, and researchers believe that only certain patients with Alzheimer’s dementia may benefit from statins. Further clinical trials are needed to confirm the potential benefits of statin use in Alzheimer’s disease.
Source link